Improving lung cancer screening with low-dose CT images and data
Official title: LOW-DOSE COMPUTED TOMOGRAPHY IMAGES AND CORRESPONDING DATA
Funded at Booz Allen Hamilton · NIH-10724040 · Data updated 2026-11-12
This study is looking to improve lung cancer screening with low-dose CT scans by finding better ways to tell which patients really need more tests after a positive result, so we can reduce unnecessary worry and costs while making sure those who need help get it faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Booz Allen Hamilton NIH-funded |
| Lab location | 1 site (Mc Lean, United States) |
| Project start | September 16, 2022 |
| Project end | September 15, 2025 |
| Funding year | 2022 |
| Award (this year) | $6,707,503 |
| NIH project number | 91022A00691022F00001-0-0-1 |
| Project ID | NIH-10724040 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have undergone low-dose CT screening for lung cancer and received positive results.
✕Less likely to help
Patients who have not been screened with low-dose CT or those without any risk factors for lung cancer may not benefit from this research.
What this research studies
This research focuses on enhancing the effectiveness of low-dose computed tomography (LDCT) for lung cancer screening by addressing the high false positive rates associated with the current screening methods. It aims to develop better predictive models to identify which patients with positive LDCT results truly require further diagnostic procedures, such as biopsies. By analyzing data from previous screenings, the research seeks to reduce unnecessary anxiety and healthcare costs while improving timely cancer diagnosis for those who need it. Patients will be involved in the evaluation of new algorithms that could refine screening processes.
Why it matters
Potential benefit: If successful, this research could lead to more accurate lung cancer screenings, reducing unnecessary procedures and anxiety for patients.
How similar studies have gone: Previous studies have shown that improving screening methodologies can significantly enhance patient outcomes, indicating potential success for this approach.
Where this research is happening
-
Booz Allen Hamilton
Mc Lean, United States Active
Researchers
- Principal investigator: Fernandez, Anna — Booz Allen Hamilton
- Study coordinator: Fernandez, Anna
Related research
Other NIH-funded projects on the same topics.
-
Developing solutions to address the opioid crisis.
This study is working to find better ways to help people struggling with opioid misuse and addiction, so they can get faster and more effective treatments that really make a difference.
-
Improving lung cancer screening accuracy with low-dose CT images and data
This study is working to make lung cancer screenings more accurate and less stressful for patients by using smart technology to help doctors figure out who really needs further testing after a low-dose CT scan.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.